Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 690690, 13 pages
http://dx.doi.org/10.1155/2015/690690
Review Article

Emerging Roles of Focal Adhesion Kinase in Cancer

1Department of Plant Pathology and Microbiology, National Taiwan University, Taipei 10617, Taiwan
2Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan
3Center for Biotechnology, National Taiwan University, Taipei 10617, Taiwan

Received 16 January 2015; Accepted 20 February 2015

Academic Editor: Hiroshi Hasegawa

Copyright © 2015 Yu-Ling Tai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. O. Hynes, “Integrins: bidirectional, allosteric signaling machines,” Cell, vol. 110, no. 6, pp. 673–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Guan, J. E. Trevithick, and R. O. Hynes, “Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein,” Cell regulation, vol. 2, no. 11, pp. 951–964, 1991. View at Google Scholar · View at Scopus
  3. M. D. Schaller, C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds, and J. Thomas Parsons, “pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 11, pp. 5192–5196, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Hanks, M. B. Calalb, M. C. Harper, and S. K. Patel, “Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 18, pp. 8487–8491, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zhao and J.-L. Guan, “Signal transduction by focal adhesion kinase in cancer,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 35–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Cooper, T. L. Shen, and J. L. Guan, “Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction,” Molecular and Cellular Biology, vol. 23, no. 22, pp. 8030–8041, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Dunty, V. Gabarra-Niecko, M. L. King, D. F. J. Ceccarelli, M. J. Eck, and M. D. Schaller, “FERM domain interaction promotes FAK signaling,” Molecular and Cellular Biology, vol. 24, no. 12, pp. 5353–5368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Lietha, X. Cai, D. F. J. Ceccarelli, Y. Li, M. D. Schaller, and M. J. Eck, “Structural basis for the autoinhibition of focal adhesion kinase,” Cell, vol. 129, no. 6, pp. 1177–1187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Han and J.-L. Guan, “Association of focal adhesion kinase with Grb7 and its role in cell migration,” The Journal of Biological Chemistry, vol. 274, no. 34, pp. 24425–24430, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. D. C. Han, T.-L. Shen, and J.-L. Guan, “Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration,” The Journal of Biological Chemistry, vol. 275, no. 37, pp. 28911–28917, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. H. R. Reiske, S.-C. Kao, L. A. Cary, J.-L. Guan, J.-F. Lai, and H.-C. Chen, “Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration,” The Journal of Biological Chemistry, vol. 274, no. 18, pp. 12361–12366, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Schaller, J. D. Hildebrand, J. D. Shannon, J. W. Fox, R. R. Vines, and J. T. Parsons, “Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src,” Molecular and Cellular Biology, vol. 14, no. 3, pp. 1680–1688, 1994. View at Google Scholar · View at Scopus
  13. M. B. Calalb, T. R. Polte, and S. K. Hanks, “Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases,” Molecular and Cellular Biology, vol. 15, no. 2, pp. 954–963, 1995. View at Google Scholar · View at Scopus
  14. D. D. Schlaepfer and T. Hunter, “Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases,” Molecular and Cellular Biology, vol. 16, no. 10, pp. 5623–5633, 1996. View at Google Scholar
  15. D. D. Schlaepfer, S. K. Hanks, T. Hunter, and P. Van der Geer, “Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase,” Nature, vol. 372, no. 6508, pp. 786–791, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. T.-L. Shen and J.-L. Guan, “Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts,” FEBS Letters, vol. 499, no. 1-2, pp. 176–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. G. W. McLean, N. O. Carragher, E. Avizienyte, J. Evans, V. G. Brunton, and M. C. Frame, “The role of focal-adhesion kinase in cancer—a new therapeutic opportunity,” Nature Reviews Cancer, vol. 5, no. 7, pp. 505–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Cretu and P. C. Brooks, “Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 391–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Whiteside, “The tumor microenvironment and its role in promoting tumor growth,” Oncogene, vol. 27, no. 45, pp. 5904–5912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ungefroren, S. Sebens, D. Seidl, H. Lehnert, and R. Hass, “Interaction of tumor cells with the microenvironment,” Cell Communication and Signaling, vol. 9, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-N. Kim, K. H. Koo, J. Y. Sung, U.-J. Yun, and H. Kim, “Anoikis resistance: an essential prerequisite for tumor metastasis,” International Journal of Cell Biology, vol. 2012, Article ID 306879, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Reddig and R. L. Juliano, “Clinging to life: cell to matrix adhesion and cell survival,” Cancer and Metastasis Reviews, vol. 24, no. 3, pp. 425–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Bouchard, M.-J. Demers, S. Thibodeau et al., “Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways,” Journal of Cellular Physiology, vol. 212, no. 3, pp. 717–728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Horowitz, D. S. Rogers, V. Sharma et al., “Combinatorial activation of FAK and AKT by transforming growth factor-β1 confers an anoikis-resistant phenotype to myofibroblasts,” Cellular Signalling, vol. 19, no. 4, pp. 761–771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhang, H. Lu, P. Dazin, and Y. Kapila, “Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin αv mediate survival signals through focal adhesion kinase,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 48342–48349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Kamarajan and Y. L. Kapila, “An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK,” Apoptosis, vol. 12, no. 12, pp. 2221–2231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. S. Duxbury, H. Ito, M. J. Zinner, S. W. Ashley, and E. E. Whang, “Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells,” Surgery, vol. 135, no. 5, pp. 555–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Sonoda, Y. Matsumoto, M. Funakoshi, D. Yamamoto, S. K. Hanks, and T. Kasahara, “Anti-apoptotic role of focal adhesion kinase (FAK): induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60,” Journal of Biological Chemistry, vol. 275, no. 21, pp. 16309–16315, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Huang, M. Khoe, M. Befekadu et al., “Focal adhesion kinase mediates cell survival via NF-κB and ERK signaling pathways,” The American Journal of Physiology—Cell Physiology, vol. 292, no. 4, pp. C1339–C1352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Kurenova, L.-H. Xu, X. Yang et al., “Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein,” Molecular and Cellular Biology, vol. 24, no. 10, pp. 4361–4371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. K. B. Dunn, M. Heffler, and V. M. Golubovskaya, “Evolving therapies and FAK inhibitors for the treatment of cancer,” Anti-Cancer Agents in Medicinal Chemistry, vol. 10, no. 10, pp. 722–734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-H. Zhao, H. Reiske, and J.-L. Guan, “Regulation of the cell cycle by focal adhesion kinase,” The Journal of Cell Biology, vol. 143, no. 7, pp. 1997–2008, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zhao, R. Pestell, and J.-L. Guan, “Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression,” Molecular Biology of the Cell, vol. 12, no. 12, pp. 4066–4077, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Ding, J. R. Grammer, M. A. Nelson, J.-L. Guan, J. E. Stewart Jr., and C. L. Gladson, “p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain,” The Journal of Biological Chemistry, vol. 280, no. 8, pp. 6802–6815, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. T. Zilfou and S. W. Lowe, “Tumor suppressive functions of p53,” Cold Spring Harbor perspectives in biology, vol. 1, no. 5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. V. M. Golubovskaya, R. Finch, and W. G. Cance, “Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 25008–25021, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S.-T. Lim, X. L. Chen, Y. Lim et al., “Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation,” Molecular Cell, vol. 29, no. 1, pp. 9–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. A. M. van Miltenburg, M. J. van Nimwegen, I. Tijdens et al., “Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation,” British Journal of Cancer, vol. 110, no. 11, pp. 2747–2755, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Vicente-Manzanares, D. J. Webb, and A. R. Horwitz, “Cell migration at a glance,” Journal of Cell Science, vol. 118, no. 21, pp. 4917–4919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Shi and D. Boettiger, “A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397,” Molecular Biology of the Cell, vol. 14, no. 10, pp. 4306–4315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. L. A. Cary, D. C. Han, T. R. Polte, S. K. Hanks, and J.-L. Guan, “Identification of p130(Cas) as a mediator of focal adhesion kinase-promoted cell migration,” The Journal of Cell Biology, vol. 140, no. 1, pp. 211–221, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Webb, K. Donais, L. A. Whitmore et al., “FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly,” Nature Cell Biology, vol. 6, no. 2, pp. 154–161, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Huang, Z. Rajfur, C. Borchers, M. D. Schaller, and K. Jacobson, “JNK phosphorylates paxillin and regulates cell migration,” Nature, vol. 424, no. 6945, pp. 219–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. P.-Y. Chu, L.-Y. Huang, C.-H. Hsu et al., “Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20215–20226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. T. L. Shen, D. C. Han, and J. L. Guan, “Association of Grb7 with phosphoinositides and its role in the regulation of cell migration.,” The Journal of Biological Chemistry, vol. 277, no. 32, pp. 29069–29077, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. N. O. Carragher, M. A. Westhoff, V. J. Fincham, M. D. Schaller, and M. C. Frame, “A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src,” Current Biology, vol. 13, no. 16, pp. 1442–1450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. J. Franco, M. A. Rodgers, B. J. Perrin et al., “Calpain-mediated proteolysis of talin regulates adhesion dynamics,” Nature Cell Biology, vol. 6, no. 10, pp. 977–983, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. K. T. Chan, D. A. Bennin, and A. Huttenlocher, “Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK),” The Journal of Biological Chemistry, vol. 285, no. 15, pp. 11418–11426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Yilmaz and G. Christofori, “EMT, the cytoskeleton, and cancer cell invasion,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 15–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Krugmann, I. Jordens, K. Gevaert, M. Driessens, J. Vandekerckhove, and A. Hall, “Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex,” Current Biology, vol. 11, no. 21, pp. 1645–1655, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. A. J. Ridley, “Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking,” Trends in Cell Biology, vol. 16, no. 10, pp. 522–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. J. D. Hildebrand, J. M. Taylor, and J. T. Parsons, “An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase,” Molecular and Cellular Biology, vol. 16, no. 6, pp. 3169–3178, 1996. View at Google Scholar · View at Scopus
  53. X. Wu, S. Suetsugu, L. A. Cooper, T. Takenawa, and J.-L. Guan, “Focal adhesion kinase regulation of N-WASP subcellular localization and function,” The Journal of Biological Chemistry, vol. 279, no. 10, pp. 9565–9576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. P. S. Steeg, “Tumor metastasis: Mechanistic insights and clinical challenges,” Nature Medicine, vol. 12, no. 8, pp. 895–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Lim, I. Han, J. Jeon, H. Park, Y.-Y. Bahk, and E.-S. Oh, “Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for ras transformation of fibroblasts,” The Journal of Biological Chemistry, vol. 279, no. 28, pp. 29060–29065, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Lamouille, J. Xu, and R. Derynck, “Molecular mechanisms of epithelial-mesenchymal transition,” Nature Reviews Molecular Cell Biology, vol. 15, no. 3, pp. 178–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Avizienyte and M. C. Frame, “Src and FAK signalling controls adhesion fate and the epithelial-to- mesenchymal transition,” Current Opinion in Cell Biology, vol. 17, no. 5, pp. 542–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. F. J. Sulzmaier, C. Jean, and D. D. Schlaepfer, “FAK in cancer: mechanistic findings and clinical applications,” Nature Reviews Cancer, vol. 14, no. 9, pp. 598–610, 2014. View at Publisher · View at Google Scholar
  59. A. Serrels, M. Canel, V. G. Brunton, and M. C. Frame, “Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging,” Cell Adhesion & Migration, vol. 5, no. 4, pp. 360–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Cicchini, I. Laudadio, F. Citarella et al., “TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling,” Experimental Cell Research, vol. 314, no. 1, pp. 143–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. L. J. Kornberg, “Focal adhesion kinase and its potential involvement in tumor invasion and metastasis,” Head & Neck, vol. 20, no. 8, pp. 745–752, 1998. View at Publisher · View at Google Scholar
  62. R.-K. Li, W.-Y. Zhao, F. Fang et al., “Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 2, pp. 269–281, 2015. View at Publisher · View at Google Scholar
  63. D. A. Hsia, S. K. Mitra, C. R. Hauck et al., “Differential regulation of cell motility and invasion by FAK,” The Journal of Cell Biology, vol. 160, no. 5, pp. 753–767, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. S. K. Mitra, S.-T. Lim, A. Chi, and D. D. Schlaepfer, “Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model,” Oncogene, vol. 25, no. 32, pp. 4429–4440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Kong, G. Li, Y. Yuan et al., “MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression,” PLoS ONE, vol. 7, no. 8, Article ID e41523, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Jiang, L. Liu, J. Ye, H. Liu, S. Xing, and Y. Wu, “Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 9, pp. 1295–1302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. L.-H. Xu, X. Yang, R. J. Craven, and W. G. Cance, “The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells,” Cell Growth and Differentiation, vol. 9, no. 12, pp. 999–1005, 1998. View at Google Scholar · View at Scopus
  68. K. Tsutsumi, T. Kasaoka, H. M. Park, H. Nishiyama, M. Nakajima, and T. Honda, “Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase,” International Journal of Oncology, vol. 33, no. 1, pp. 215–244, 2008. View at Google Scholar · View at Scopus
  69. A. Richardson and J. T. Parsons, “A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK,” Nature, vol. 380, no. 6574, pp. 538–540, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. van Nimwegen, S. Verkoeijen, L. van Buren, D. Burg, and B. van de Water, “Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation,” Cancer Research, vol. 65, no. 11, pp. 4698–4706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. C. R. Hauck, D. A. Hsia, X. S. Puente, D. A. Cheresh, and D. D. Schlaepfer, “FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth,” The EMBO Journal, vol. 21, no. 23, pp. 6289–6302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Li, X. Zhang, L. Cheng et al., “RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice,” Cancer Gene Therapy, vol. 20, no. 2, pp. 101–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Bjerkvig, B. B. Tysnes, K. S. Aboody, J. Najbauer, and A. J. A. Terzis, “The origin of the cancer stem cell: current controversies and new insights,” Nature Reviews Cancer, vol. 5, no. 11, pp. 899–904, 2005. View at Google Scholar · View at Scopus
  74. M. Dean, T. Fojo, and S. Bates, “Tumour stem cells and drug resistance,” Nature Reviews Cancer, vol. 5, no. 4, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Luo, H. Fan, T. Nagy et al., “Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells,” Cancer Research, vol. 69, no. 2, pp. 466–474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Fan and J.-L. Guan, “Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity,” Journal of Biological Chemistry, vol. 286, no. 21, pp. 18573–18582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Schober and E. Fuchs, “Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 26, pp. 10544–10549, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Luo, X. Zhao, S. Chen, S. Liu, M. S. Wicha, and J.-L. Guan, “Distinct FAK activities determine progenitor and mammary stem cell characteristics,” Cancer Research, vol. 73, no. 17, pp. 5591–5602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Fan, X. Zhao, S. Sun, M. Luo, and J.-L. Guan, “Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo,” The Journal of Biological Chemistry, vol. 288, no. 5, pp. 3322–3333, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. F. R. Balkwill, M. Capasso, and T. Hagemann, “The tumor microenvironment at a glance,” Journal of Cell Science, vol. 125, no. 23, pp. 5591–5596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. D. S. Harburger and D. A. Calderwood, “Integrin signalling at a glance,” Journal of Cell Science, vol. 122, no. 2, pp. 159–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. D. T. Butcher, T. Alliston, and V. M. Weaver, “A tense situation: forcing tumour progression,” Nature Reviews Cancer, vol. 9, no. 2, pp. 108–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. S. L. Payne, B. Fogelgren, A. R. Hess et al., “Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism,” Cancer Research, vol. 65, no. 24, pp. 11429–11436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Laczko, K. M. Szauter, M. K. Jansen et al., “Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes,” Neuropathology and Applied Neurobiology, vol. 33, no. 6, pp. 631–643, 2007. View at Publisher · View at Google Scholar
  85. A.-M. Baker, D. Bird, G. Lang, T. R. Cox, and J. T. Erler, “Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK,” Oncogene, vol. 32, no. 14, pp. 1863–1868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. K. R. Levental, H. Yu, L. Kass et al., “Matrix crosslinking forces tumor progression by enhancing integrin signaling,” Cell, vol. 139, no. 5, pp. 891–906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J. K. Mouw, Y. Yui, L. Damiano et al., “Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression,” Nature Medicine, vol. 20, no. 4, pp. 360–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. H. Bae, K. L. Mui, B. Y. Hsu et al., “A FAK-Cas-Rac-lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling,” Science Signaling, vol. 7, no. 330, p. ra57, 2014. View at Publisher · View at Google Scholar
  89. B. Tavora, S. Batista, L. E. Reynolds et al., “Endothelial FAK is required for tumour angiogenesis,” EMBO Molecular Medicine, vol. 2, no. 12, pp. 516–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. T.-L. Shen, A. Y.-J. Park, A. Alcaraz et al., “Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis,” Journal of Cell Biology, vol. 169, no. 6, pp. 941–952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Braren, H. Hu, Y. H. Kim, H. E. Beggs, L. F. Reichardt, and R. Wang, “Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation,” The Journal of Cell Biology, vol. 172, no. 1, pp. 151–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. T. R. Polte, A. J. Naftilan, and S. K. Hanks, “Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II,” Journal of Cellular Biochemistry, vol. 55, no. 1, pp. 106–119, 1994. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Haskell, M. Natarajan, T. P. Hecker et al., “Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells,” Clinical Cancer Research, vol. 9, no. 6, pp. 2157–2165, 2003. View at Google Scholar · View at Scopus
  94. L. H. Romer, N. McLean, C. E. Turner, and K. Burridge, “Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells,” Molecular Biology of the Cell, vol. 5, no. 3, pp. 349–361, 1994. View at Publisher · View at Google Scholar · View at Scopus
  95. J. H. Qi and L. Claesson-Welsh, “VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase,” Experimental Cell Research, vol. 263, no. 1, pp. 173–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. I. Kim, H. G. Kim, S.-O. Moon et al., “Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion,” Circulation Research, vol. 86, no. 9, pp. 952–959, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Jean, X. L. Chen, J.-O. Nam et al., “Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function,” The Journal of Cell Biology, vol. 204, no. 2, pp. 247–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Noy and J. W. Pollard, “Tumor-associated macrophages: from mechanisms to therapy,” Immunity, vol. 41, no. 1, pp. 49–61, 2014. View at Publisher · View at Google Scholar
  99. M. Y. Abshire, K. S. Thomas, K. A. Owen, and A. H. Bouton, “Macrophage motility requires distinct alpha5beta1/FAK and alpha4beta1/paxillin signaling events,” Journal of Leukocyte Biology, vol. 89, no. 2, pp. 251–257, 2011. View at Publisher · View at Google Scholar
  100. J. B. Stokes, S. J. Adair, J. K. Slack-Davis et al., “Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment,” Molecular Cancer Therapeutics, vol. 10, no. 11, pp. 2135–2145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. B. Thapa, B.-H. Koo, Y.-H. Kim, H.-J. Kwon, and D.-S. Kim, “Plasminogen activator inhibitor-1 regulates infiltration of macrophages into melanoma via phosphorylation of FAK-Tyr925,” Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1696–1701, 2014. View at Google Scholar
  102. P. C. Chen, H. C. Cheng, J. Wang et al., “Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment,” Oncotarget, vol. 5, no. 6, pp. 1595–1608, 2014. View at Google Scholar
  103. R. Chen, Z. Zhang, Z. Xue et al., “Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin α, TGF-β and α-SMA,” Cell Biology International, vol. 38, no. 7, pp. 803–808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Chanmee, P. Ontong, K. Konno, and N. Itano, “Tumor-associated macrophages as major players in the tumor microenvironment,” Cancers, vol. 6, no. 3, pp. 1670–1690, 2014. View at Publisher · View at Google Scholar
  105. B. Rothhut, C. Ghoneim, F. Antonicelli, and M. Soula-Rothhut, “Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase,” Biochimie, vol. 89, no. 5, pp. 613–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. Q. Wang, Y. Wang, D. Fritz, D. Rajshankar, G. P. Downey, and C. A. McCulloch, “Interactions of the protein-tyrosine phosphatase-alpha with the focal adhesion targeting domain of focal adhesion kinase are involved in interleukin-1 signaling in fibroblasts,” The Journal of Biological Chemistry, vol. 289, no. 26, pp. 18427–18441, 2014. View at Publisher · View at Google Scholar
  107. S. Ramanathan and N. Jagannathan, “Tumor associated macrophage: a review on the phenotypes, traits and functions,” Iranian Journal of Cancer Prevention, vol. 7, no. 1, pp. 1–8, 2014. View at Google Scholar · View at Scopus
  108. J. Zhu, Y.-S. Wang, J. Zhang et al., “Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells,” Experimental Eye Research, vol. 88, no. 5, pp. 910–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. E. A. Sheta, M. A. Harding, M. R. Conaway, and D. Theodorescu, “Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor,” Journal of the National Cancer Institute, vol. 92, no. 13, pp. 1065–1073, 2000. View at Publisher · View at Google Scholar · View at Scopus
  110. L. Neff, M. Zeisel, V. Druet et al., “ERK 1/2- and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, requires focal adhesion kinase,” Journal of Biological Chemistry, vol. 278, no. 30, pp. 27721–27728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Eitel, T. Heise, U. Thiesen, and P. Dersch, “Cell invasion and IL-8 production pathways initiated by YadA of Yersinia pseudotuberculosis require common signalling molecules (FAK, c-Src, Ras) and distinct cell factors,” Cellular Microbiology, vol. 7, no. 1, pp. 63–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. M. R. Shurin, “Dual role of immunomodulation by anticancer chemotherapy,” Nature Medicine, vol. 19, no. 1, pp. 20–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. M. M. Mueller and N. E. Fusenig, “Friends or foes—bipolar effects of the tumour stroma in cancer,” Nature Reviews Cancer, vol. 4, no. 11, pp. 839–849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Kalluri and M. Zeisberg, “Fibroblasts in cancer,” Nature Reviews Cancer, vol. 6, no. 5, pp. 392–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. H. E. Barker, D. Bird, G. Lang, and J. T. Erler, “Tumor-secreted LOXL2 activates fibroblasts through fak signaling,” Molecular Cancer Research, vol. 11, no. 11, pp. 1425–1436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. N. K. Zouq, J. A. Keeble, J. Lindsay et al., “FAK engages multiple pathways to maintain survival of fibroblasts and epithelia—differential roles for paxillin and p130Cas,” Journal of Cell Science, vol. 122, no. 3, pp. 357–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. G. W. McLean, N. H. Komiyama, B. Serrels et al., “Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression,” Genes & Development, vol. 18, no. 24, pp. 2998–3003, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Navab, D. Strumpf, B. Bandarchi et al., “Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 17, pp. 7160–7165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. T. M. Weiner, E. T. Liu, R. J. Craven, and W. G. Cance, “Expression of focal adhesion kinase gene and invasive cancer,” The Lancet, vol. 342, no. 8878, pp. 1024–1025, 1993. View at Publisher · View at Google Scholar · View at Scopus
  120. L. Tremblay, W. Hauck, A. G. Aprikian, L. R. Begin, A. Chapdelaine, and S. Chevalier, “Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma,” International Journal of Cancer, vol. 68, no. 2, pp. 164–171, 1996. View at Publisher · View at Google Scholar
  121. P. L. Judson, X. He, W. G. Cance, and L. Van Le, “Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma,” Cancer, vol. 86, no. 8, pp. 1551–1556, 1999. View at Publisher · View at Google Scholar
  122. A. L. Lark, C. A. Livasy, B. Calvo et al., “Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses,” Clinical Cancer Research, vol. 9, no. 1 I, pp. 215–222, 2003. View at Google Scholar · View at Scopus
  123. L. V. Owens, L. Xu, R. J. Craven et al., “Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors,” Cancer Research, vol. 55, no. 13, pp. 2752–2755, 1995. View at Google Scholar · View at Scopus
  124. M. Agochiya, V. G. Brunton, D. W. Owens et al., “Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells,” Oncogene, vol. 18, no. 41, pp. 5646–5653, 1999. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Canel, P. Secades, J. P. Rodrigo et al., “Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number,” Clinical Cancer Research, vol. 12, no. 11 I, pp. 3272–3279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. V. Golubovskaya, A. Kaur, and W. Cance, “Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites,” Biochimica et Biophysica Acta: Gene Structure and Expression, vol. 1678, no. 2-3, pp. 111–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. V. M. Golubovskaya, R. Finch, F. Kweh et al., “p53 regulates FAK expression in human tumor cells,” Molecular Carcinogenesis, vol. 47, no. 5, pp. 373–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. V. M. Golubovskaya, K. Conway-Dorsey, S. N. Edmiston et al., “FAK overexpression and p53 mutations are highly correlated in human breast cancer,” International Journal of Cancer, vol. 125, no. 7, pp. 1735–1738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Ding, S. Huang, S. Wu et al., “Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA,” Nature Cell Biology, vol. 12, no. 4, pp. 390–399, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. N. M. Han, R. Y. Declan Fleming, S. A. Curley, and G. E. Gallick, “Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation,” Annals of Surgical Oncology, vol. 4, no. 3, pp. 264–268, 1997. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Abdel-Ghany, H.-C. Cheng, R. C. Elble, and B. U. Pauli, “Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth,” The Journal of Biological Chemistry, vol. 277, no. 37, pp. 34391–34400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. I. Eke, Y. Deuse, S. Hehlgans et al., “β1 integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1529–1540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. T. Shibue and R. A. Weinberg, “Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 25, pp. 10290–10295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. L. V. Owens, L. Xu, G. A. Dent et al., “Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer,” Annals of Surgical Oncology, vol. 3, no. 1, pp. 100–105, 1996. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Recher, L. Ysebaert, O. Beyne-Rauzy et al., “Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis,” Cancer Research, vol. 64, no. 9, pp. 3191–3197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Albasri, W. Fadhil, J. H. Scholefield, L. G. Durrant, and M. Ilyas, “Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorectal cancer,” Anticancer Research, vol. 34, no. 8, pp. 3969–3974, 2014. View at Google Scholar
  137. J. K. Slack-Davis, K. H. Martin, R. W. Tilghman et al., “Cellular characterization of a novel focal adhesion kinase inhibitor,” The Journal of Biological Chemistry, vol. 282, no. 20, pp. 14845–14852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. Q. Shi, A. B. Hjelmeland, S. T. Keir et al., “A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth,” Molecular Carcinogenesis, vol. 46, no. 6, pp. 488–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. V. M. Golubovskaya, C. Virnig, and W. G. Cance, “TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR,” Molecular Carcinogenesis, vol. 47, no. 3, pp. 222–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. N. Kurio, T. Shimo, T. Fukazawa et al., “Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo,” Experimental Cell Research, vol. 317, no. 8, pp. 1134–1146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. N. Kurio, T. Shimo, T. Fukazawa et al., “Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma,” Oral Oncology, vol. 48, no. 11, pp. 1159–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. I. Tanjoni, C. Walsh, S. Uryu et al., “PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments,” Cancer Biology and Therapy, vol. 9, no. 10, pp. 764–777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Walsh, I. Tanjoni, S. Uryu et al., “Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models,” Cancer Biology & Therapy, vol. 9, no. 10, pp. 778–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  144. W. G. Roberts, E. Ung, P. Whalen et al., “Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271,” Cancer Research, vol. 68, no. 6, pp. 1935–1944, 2008. View at Publisher · View at Google Scholar · View at Scopus
  145. J. R. Infante, D. R. Camidge, L. R. Mileshkin et al., “Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors,” Journal of Clinical Oncology, vol. 30, no. 13, pp. 1527–1533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. E. V. Kurenova, D. L. Hunt, D. He, A. T. Magis, D. A. Ostrov, and W. G. Cance, “Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo,” Journal of Medicinal Chemistry, vol. 52, no. 15, pp. 4716–4724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. D. A. Ucar, E. Kurenova, T. J. Garrett et al., “Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth,” Cell Cycle, vol. 11, no. 17, pp. 3250–3259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. V. M. Golubovskaya, N. L. Palma, M. Zheng et al., “A small-molecule inhibitor, 5′-o-tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 4, pp. 532–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. V. M. Golubovskaya, B. Ho, M. Zheng et al., “Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth,” BMC Cancer, vol. 13, article no. 342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. V. M. Golubovskaya, B. Sumbler, B. Ho, M. Yemma, and W. G. Cance, “MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 1, pp. 18–28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. M. E. Roh, M. Cosgrove, K. Gorski, and I. S. Hitchcock, “Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies using Fak-deficient mice,” Journal of Thrombosis and Haemostasis, vol. 11, no. 9, pp. 1776–1778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  152. S. N. Hochwald, C. Nyberg, M. Zheng et al., “A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer,” Cell Cycle, vol. 8, no. 15, pp. 2435–2443, 2009. View at Publisher · View at Google Scholar · View at Scopus